- Home
- ATS vs ZLAB Comparison
ATS vs ZLAB Comparison
Compare ATS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATS
- ZLAB
- Stock Information
- Founded
- ATS 1978
- ZLAB 2013
- Country
- ATS Canada
- ZLAB China
- Employees
- ATS N/A
- ZLAB N/A
- Industry
- ATS
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ATS
- ZLAB Health Care
- Exchange
- ATS Nasdaq
- ZLAB Nasdaq
- Market Cap
- ATS 2.6B
- ZLAB 2.2B
- IPO Year
- ATS 2023
- ZLAB 2017
- Fundamental
- Price
- ATS $24.86
- ZLAB $19.88
- Analyst Decision
- ATS
- ZLAB Buy
- Analyst Count
- ATS 0
- ZLAB 6
- Target Price
- ATS N/A
- ZLAB $57.22
- AVG Volume (30 Days)
- ATS 125.8K
- ZLAB 931.8K
- Earning Date
- ATS 11-05-2025
- ZLAB 11-06-2025
- Dividend Yield
- ATS N/A
- ZLAB N/A
- EPS Growth
- ATS N/A
- ZLAB N/A
- EPS
- ATS N/A
- ZLAB N/A
- Revenue
- ATS $1,930,283,080.00
- ZLAB $441,629,000.00
- Revenue This Year
- ATS $18.03
- ZLAB $40.71
- Revenue Next Year
- ATS $5.59
- ZLAB $50.42
- P/E Ratio
- ATS N/A
- ZLAB N/A
- Revenue Growth
- ATS N/A
- ZLAB 24.14
- 52 Week Low
- ATS $20.90
- ZLAB $19.51
- 52 Week High
- ATS $33.13
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ATS 41.55
- ZLAB 18.64
- Support Level
- ATS $23.85
- ZLAB $19.51
- Resistance Level
- ATS $25.51
- ZLAB $20.29
- Average True Range (ATR)
- ATS 0.86
- ZLAB 0.76
- MACD
- ATS -0.25
- ZLAB 0.02
- Stochastic Oscillator
- ATS 18.77
- ZLAB 7.44
About ATS ATS Corporation
ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.